Remote Patient Monitoring

Europe’s healthtech market is no longer an emerging category. It is repricing, consolidating and, selectively, preparing for public markets. That is a useful correction. The companies that matter in 2026 are not simply those with the largest funding rounds or the most polished investor narrative. They are the companies proving that digital health can survive…